Comprehensive Rheumatology Workup Approach
A comprehensive rheumatology workup should follow a structured approach focusing on autoimmune markers (RF, ACPA, ANA), inflammatory markers (ESR, CRP), and complete blood count with differential to establish diagnosis, assess disease activity, and guide treatment decisions. 1
Initial Laboratory Testing
Core Laboratory Panel
Inflammatory Markers:
Autoimmune Markers:
Complete Blood Count (CBC) with differential:
Disease-Specific Testing
For suspected Systemic Lupus Erythematosus (SLE):
For suspected Vasculitis:
For suspected Antiphospholipid Syndrome:
- Anticardiolipin antibodies
- Lupus anticoagulant
- Anti-β2 glycoprotein I 3
Imaging Studies
Conventional Radiography:
- First-line imaging for detecting structural damage, particularly in hands and feet
- Limited sensitivity for early disease 1
Ultrasonography:
- Particularly valuable in seronegative RA when clinical assessment is uncertain
- More sensitive than clinical examination for detecting joint inflammation 1
Magnetic Resonance Imaging (MRI):
- More sensitive than conventional radiography for early detection of erosions
- Can detect bone edema, a strong predictor of radiographic progression 1
Classification Criteria
ACR/EULAR 2010 Classification Criteria for RA
- Based on four main parameters with a scoring system (score ≥6/10 indicates definite RA):
- Joint involvement (0-5 points)
- Serology (0-3 points)
- Acute phase reactants (0-1 point)
- Duration of symptoms (0-1 point) 1
Common Pitfalls to Avoid
- Overreliance on a single test - can lead to misdiagnosis 1
- Ordering tests without clear purpose - tests should be used to screen, confirm diagnosis, exclude possibilities, monitor therapy, or determine prognosis 5
- Ignoring clinical context - laboratory tests should supplement a thorough history and physical examination, not replace them 5, 6
- Overlooking RA in patients with only one or few affected joints initially 1
- Assuming hand stiffness in older adults is always due to osteoarthritis 1
- Delaying referral to a rheumatologist - should be within 6 weeks of symptom onset 1
Monitoring Disease Activity
- Regular assessment using validated measures such as tender and swollen joint counts, ESR, and CRP 1
- Follow-up every 3-6 months with adjustment of interventions based on response 1
- In chronic diseases, a combination of CRP and ESR may provide the most useful information 3
Special Considerations
For suspected autoinflammatory diseases (hereditary periodic fever syndromes), genetic testing may be indicated:
- Familial Mediterranean Fever (FMF): MEFV gene
- Hyperimmunoglobulinemia D syndrome: MK gene
- Cryopyrinopathies: CIAS1 gene mutations
- TNF receptor-associated periodic syndrome: TNFRSF1A gene 3
Synovial fluid analysis is primarily indicated when joint infection is suspected 3